Page 45 - Roche Diagnostics News Today

United Bank Limited is partnering with National Incubation Center, Karachi, to organise the BuiltByHer 3.0 Hackathon to address...

The Medical Equipment and Healthcare Products exhibition area at the CIIE has become an important platform for global pharmaceutical enterprises to explore the Chinese market and share development opportunities in China.

In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and Drug Administration to maintain blood glucose levels in the recommended range.

In this article, Roche discusses the increasing automation of science and next-generation sequencing (NGS) in particular and demonstrates an efficient DNA hybridization workflow.

Roche has announced the launch of a human papillomavirus (HPV) self sampling solution for women at risk of cervical cancer. 

DNA diagnostics market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.

The primary reasons propelling the global Molecular Quality Controls Market are the increasing number of licensed medical laboratories, the expansion of third-party quality controls, and the

/PRNewswire/ -- Verified Market Research recently published a report, "Molecular Quality Controls Market" By Product (Instrument-Specific Controls, Independent...

New research establishes Nordic Bioscience’s ECM biomarker PRO-C6, as a potential biomarker for trial enrichment in patients with HFpEF. 

Emerging markets such as Brazil, India and China are expected to provide significant growth opportunities for the major players in the market.